NIH-funded research U01 cooperative agreement

Using wearables and smart pumps to lower the risk of unrecognized low blood sugar

Official title: Using technology to define and mitigate risk of impaired awareness of hypoglycemia in patients with type 1 diabetes

Funded at University of California, San Diego · NIH-11319806 · Data updated 2026-11-12

This project uses continuous glucose monitors and hybrid closed-loop insulin systems to find people with impaired awareness of hypoglycemia in type 1 diabetes and help restore their ability to notice low blood sugar.

More Diabetes research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 25, 2022
Project endDecember 31, 2027
Funding year2026
Award (this year)$879,491
NIH project number5U01DK135121-04
Project IDNIH-11319806 on NIH RePORTER

Who could benefit from this research

Could help

Adults (18+) with type 1 diabetes, particularly those who have frequent hypoglycemia or suspect they do not sense low blood sugar, are the ideal candidates.

Less likely to help

People without type 1 diabetes (including most with type 2), children under 18, or those who already reliably sense hypoglycemia are unlikely to receive direct benefit from this project.

What this research studies

You would wear a blinded continuous glucose monitor (CGM) for about 10 days so researchers can look for CGM patterns linked to poor awareness of low blood sugar. After that, you would have a controlled hypoglycemic clamp visit where hormones and symptoms during low blood sugar are measured. The team plans to enroll roughly 112 adults with type 1 diabetes to compare CGM metrics with counterregulatory hormone responses and symptom scores. In a second phase, participants will use hybrid closed-loop insulin delivery to see whether modern automated insulin management can help restore hypoglycemia awareness.

Why it matters

Potential benefit: If successful, this work could help clinicians identify people at high risk for dangerous low blood sugar and reduce that risk by using modern insulin-delivery technology.

How similar studies have gone: Previous work shows CGM metrics and closed-loop systems can reduce time spent in hypoglycemia, but combining CGM pattern identification with hormonal clamp testing to restore awareness is a newer and less-tested approach.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Pettus, Jeremy H — University of California, San Diego
  • Study coordinator: Pettus, Jeremy H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.